Table 4.
P (MR results) | P (Cochrane's Q) | P (Pleiotropy) | |||||||
---|---|---|---|---|---|---|---|---|---|
IVW | MR-Egger | WM | MLE | MR-RAPS | IVW | MR-Egger | MR-Egger regression | MR-PRESSO | |
Aldo | 0.39 | 0.71 | 0.58 | 0.64 | 0.65 | 0.89 | 0.89 | 0.46 | 0.920 |
A4 | 0.79 | 0.59 | 0.79 | 0.52 | 0.53 | 0.38 | 0.33 | 0.63 | 0.271 |
P4 | 0.82 | 0.70 | 0.45 | 0.94 | 0.94 | 0.18 | 0.15 | 0.74 | 0.196 |
17-OHP | 0.43 | 0.21 | 0.74 | 0.73 | 0.74 | 0.51 | 0.54 | 0.29 | 0.564 |
T/E2 | 0.75 | 0.78 | 0.81 | 0.68 | 0.68 | 0.07 | 0.06 | 0.67 | 0.066 |
MR, Mendelian randomization; IVW, Inverse variance weighted; WM, Weighted median; MLE, maximum likelihood estimator; MR-RAPS, MR robust adjusted profile score; Aldo, aldosterone; A4, androstenedione; P4, progesterone; 17-OHP, hydroxyprogesterone; T/E, Testosterone_Estradiol_Ratio.